{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:55:53Z","timestamp":1781279753495,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"MEXT-Supported Program for the Strategic Research Foundation at Private Universities","award":["S1411037"],"award-info":[{"award-number":["S1411037"]}]},{"name":"\u201cAntiaging\u201d Project for Private Universities"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.tox.2018.12.003","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T12:58:28Z","timestamp":1544619508000},"page":"33-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Critical role of Cav3.2 T-type calcium channels in the peripheral neuropathy induced by bortezomib, a proteasome-inhibiting chemotherapeutic agent, in mice"],"prefix":"10.1016","volume":"413","author":[{"given":"Shiori","family":"Tomita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyo","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaya","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Tsubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy Du","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Toyooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3163-807X","authenticated-orcid":false,"given":"Atsufumi","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2018.12.003_bib0005","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00204-014-1316-5","article-title":"Bortezomib-induced peripheral neurotoxicity: an update","volume":"88","author":"Argyriou","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2018.12.003_bib0010","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917714693","article-title":"Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; Cause and effect?","volume":"13","author":"Aromolaran","year":"2017","journal-title":"Mol. Pain"},{"key":"10.1016\/j.tox.2018.12.003_bib0015","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1038\/srep06370","article-title":"Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl\/6 mice","volume":"4","author":"Boehmerle","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2018.12.003_bib0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.tox.2018.12.003_bib0025","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1111\/bph.14063","article-title":"Characterization of a rat model of bortezomib-induced painful neuropathy","volume":"174","author":"Duggett","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tox.2018.12.003_bib0030","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/j.pain.0000000000000939","article-title":"Paclitaxel-induced painful neuropathy is associated with changes in mitochondrial bioenergetics, glycolysis, and an energy deficit in dorsal root ganglia neurons","volume":"158","author":"Duggett","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.tox.2018.12.003_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025212","article-title":"Global inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathy","volume":"6","author":"Fidanboylu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tox.2018.12.003_bib0040","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/bja\/aex229","article-title":"Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review","volume":"119","author":"Flatters","year":"2017","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.tox.2018.12.003_bib0045","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pain.2012.10.023","article-title":"State-dependent properties of a new T-type calcium channel blocker enhance Cav3.2 selectivity and support analgesic effects","volume":"154","author":"Francois","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.tox.2018.12.003_bib0050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bcp.2015.08.005","article-title":"Functional upregulation of the H2S\/Cav3.2 channel pathway accelerates secretory function in neuroendocrine-differentiated human prostate cancer cells","volume":"97","author":"Fukami","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2018.12.003_bib0055","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.neuron.2014.07.036","article-title":"The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity","volume":"83","author":"Garcia-Caballero","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.tox.2018.12.003_bib0060","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1152\/jn.01031.2007","article-title":"Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve","volume":"99","author":"Jagodic","year":"2008","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.tox.2018.12.003_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2016.12.007","article-title":"Proteasome inhibitors in cancer therapy: treatment regimen and peripheral neuropathy as a side effect","volume":"103","author":"Kaplan","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tox.2018.12.003_bib0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pain.2007.01.026","article-title":"Hydrogen sulfide as a novel nociceptive messenger","volume":"132","author":"Kawabata","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.tox.2018.12.003_bib0075","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/j.pain.0000000000000774","article-title":"Dorsal root ganglion neurons become hyperexcitable and increase expression of voltage-gated T-type calcium channels (Cav3.2) in paclitaxel-induced peripheral neuropathy","volume":"158","author":"Li","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.tox.2018.12.003_bib0080","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1523\/JNEUROSCI.0899-17.2017","article-title":"DRG voltage-gated sodium channel 1.7 is upregulated in paclitaxel-induced neuropathy in rats and in humans with neuropathic pain","volume":"38","author":"Li","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tox.2018.12.003_bib0085","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4161\/cc.27476","article-title":"Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy","volume":"13","author":"Meregalli","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tox.2018.12.003_bib0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jphs.2016.02.008","article-title":"The prostaglandin E2\/EP4 receptor\/cyclic AMP\/T-type Ca2+ channel pathway mediates neuritogenesis in sensory neuron-like ND7\/23 cells","volume":"130","author":"Mitani","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.tox.2018.12.003_bib0095","doi-asserted-by":"crossref","first-page":"12577","DOI":"10.1523\/JNEUROSCI.2206-07.2007","article-title":"Molecular mechanisms of subtype-specific inhibition of neuronal T-type calcium channels by ascorbate","volume":"27","author":"Nelson","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tox.2018.12.003_bib0100","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1016\/j.bmc.2018.07.023","article-title":"Design and synthesis of novel anti-hyperalgesic agents based on 6-prenylnaringenin as the T-type calcium channel blockers","volume":"26","author":"Nguyen","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.tox.2018.12.003_bib0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tox.2016.07.016","article-title":"Involvement of high mobility group box 1 in the development and maintenance of chemotherapy-induced peripheral neuropathy in rats","volume":"365","author":"Nishida","year":"2016","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2018.12.003_bib0110","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neuroscience.2011.05.004","article-title":"Inhibition of T-type calcium channels and hydrogen sulfide-forming enzyme reverses paclitaxel-evoked neuropathic hyperalgesia in rats","volume":"188","author":"Okubo","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.tox.2018.12.003_bib0115","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1476-5381.2012.01835.x","article-title":"Topical application of disodium isostearyl 2-O-L-ascorbyl phosphate, an amphiphilic ascorbic acid derivative, reduces neuropathic hyperalgesia in rats","volume":"166","author":"Okubo","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tox.2018.12.003_bib0120","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tox.2017.11.012","article-title":"Zinc deficiency promotes cystitis-related bladder pain by enhancing function and expression of Cav3.2 in mice","volume":"393","author":"Ozaki","year":"2018","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2018.12.003_bib0125","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogawski","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tox.2018.12.003_bib0130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1254\/jphs.13R05CP","article-title":"T-type calcium channels: functional regulation and implication in pain signaling","volume":"122","author":"Sekiguchi","year":"2013","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.tox.2018.12.003_bib0135","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/j.pain.0000000000000565","article-title":"Therapeutic potential of RQ-00311651, a novel T-type Ca2+ channel blocker, in distinct rodent models for neuropathic and visceral pain","volume":"157","author":"Sekiguchi","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.tox.2018.12.003_bib0140","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neuropharm.2018.06.020","article-title":"Blockade of T-type calcium channels by 6-prenylnaringenin, a hop component, alleviates neuropathic and visceral pain in mice","volume":"138","author":"Sekiguchi","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tox.2018.12.003_bib0145","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/dvdy.20517","article-title":"Expression of voltage sensitive calcium channel (VSCC) L-type Cav1.2 (alpha1C) and T-type Cav3.2 (alpha1H) subunits during mouse bone development","volume":"234","author":"Shao","year":"2005","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.tox.2018.12.003_bib0150","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.celrep.2017.02.050","article-title":"TRPV1 nociceptor activity initiates USP5\/T-type channel-mediated plasticity","volume":"18","author":"Stemkowski","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.tox.2018.12.003_bib0155","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pain.2010.04.022","article-title":"Upregulation of Cav3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain","volume":"150","author":"Takahashi","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.tox.2018.12.003_bib0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/adsc.200600454","article-title":"Selective C-6 prenylation of flavonoids via europium (III)-catalyzed claisen rearrangement and cross-metashesis","volume":"349","author":"Tischer","year":"2007","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.tox.2018.12.003_bib0165","doi-asserted-by":"crossref","first-page":"15489","DOI":"10.1074\/jbc.M111.310763","article-title":"Transcriptional regulation of T-type calcium channel CaV3.2: bi-directionality by early growth response 1 (Egr1) and repressor element 1 (RE-1) protein-silencing transcription factor (REST)","volume":"287","author":"van Loo","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2018.12.003_bib0170","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jpain.2016.02.011","article-title":"Dorsal root ganglion infiltration by macrophages contributes to paclitaxel chemotherapy-induced peripheral neuropathy","volume":"17","author":"Zhang","year":"2016","journal-title":"J. Pain"}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X18303950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X18303950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:39:29Z","timestamp":1759534769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X18303950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":34,"alternative-id":["S0300483X18303950"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2018.12.003","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Critical role of Cav3.2 T-type calcium channels in the peripheral neuropathy induced by bortezomib, a proteasome-inhibiting chemotherapeutic agent, in mice","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2018.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}